Close
ACHEMA MIDDLE EAST 2026

Samsung Bioepis and C-Bridge Capital to Develop and Commercialize Next-Generation Biosimilars in China

Samsung Bioepis Co., Ltd. announced its expansion in mainland China through a licensing agreement with C-Bridge Capital. The agreement covers multiple biosimilar candidates from...

IQVIA Launches IQVIA Biotech, Dedicated to Emerging Biotech and Biopharma Industry

IQVIA announced the launch of IQVIA™ Biotech and its new approach to delivering tailored clinical and commercial solutions for small biotech and biopharma companies....

Enzene Biosciences Chooses Novasep BioSC Pilot Chromatography for Its Automated End to End Continuous Manufacture of mAb

Novasep, a leading supplier of services and technologies for the life sciences industry, announces Enzene Biosciences (India) has chosen BioSC® Pilot for purification of...

AstraZeneca collaborates with Aptamer Group on next-gen drug delivery devices

The two-year project will see Astrazeneca exploring the use of aptamer technology for targeted delivery of the kidney. Aptamers are emerging as promising therapeutic agents....

Marken To Build New GMP-Compliant Facility In Philadelphia

Marken announced the expansion of its facilities in Philadelphia to include more space for logistics operations as well as a new GMP-compliant storage and...

Sharp enhances clinical IRT solution with latest investment

Sharp has announced a $650,000 investment into enhancing its Interactive Response Technology (IRT) solution. Sharp’s IRT solution is used to manage patient interactions and...

Janssen Enters Worldwide Collaboration and License Agreement with MeiraGTx

The Janssen Pharmaceutical Companies of Johnson & Johnson announced a worldwide collaboration and license agreement with MeiraGTx Holdings plc, a clinical-stage gene therapy company,...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...